文献速递重症综合管理与镇静镇痛

成年内科ICU患者主治医师最大连续性2周与1周比较:两中心目标试验模拟

Two Weeks Versus One Week of Maximal Patient-Intensivist Continuity for Adult Medical Intensive Care Patients: A Two-Center Target Trial Emulation.
PubMed 文献 · Crit Care Med · 2024-05-07
一句话结论在两所美国内科ICU中,主治医师最大连续性2周与1周相比,医院死亡率、ICU住院时长及机械通气时长均无差异。

该回顾性队列研究在两个美国城市教学医院内科ICU(主治医师按2周轮班)中,采用目标试验模拟比较入ICU时处于主治医师第一周(代表2周最大连续性)与第二周(代表1周最大连续性)患者的结局。共纳入2571例患者(第一周1254例,第二周1317例),使用逆概率加权调整基线差异,随机效应Meta分析计算总体效应。结果显示,2周与1周最大连续性相比,调整后死亡率(OR 1.01,95%CI 0.96-1.06)和ICU住院时长(-0.25天,95%CI -0.82至+0.32天)均无差异;机械通气患者中调整后死亡率(OR 1.00,95%CI 0.87-1.16)、ICU住院时长(+0.06天,95%CI -0.78至+0.91天)和机械通气时长(+0.37天,95%CI -0.46至+1.21天)也无差异。结论认为2周最大连续性未带来临床结局差异。

要点

  • 两中心2571例成人内科ICU患者中,主治医师最大连续性2周与1周相比,调整后医院死亡率OR 1.01(95%CI 0.96-1.06),无差异。
  • ICU住院时长在2周与1周最大连续性间无差异:-0.25天(95%CI -0.82至+0.32天)。
  • 机械通气患者中,2周与1周最大连续性相比,调整后死亡率OR 1.00(95%CI 0.87-1.16)、ICU住院时长+0.06天(95%CI -0.78至+0.91天)、机械通气时长+0.37天(95%CI -0.46至+1.21天),均无差异。
  • 研究采用目标试验模拟和逆概率加权调整基线差异,随机效应Meta分析计算总体效应。

适用人群与场景

  • 18岁及以上、于2017年3月1日至2020年2月28日入住研究ICU的患者。
  • 两所美国城市教学医院内科ICU,主治医师按2周服务区块排班;A站点位于中西部,B站点位于东北部。

研究设计与关键结果

  • 研究设计:回顾性队列研究,应用目标试验模拟,比较入ICU时处于主治医师第一周(代表2周最大连续性)与第二周(代表1周最大连续性)的患者结局;使用逆概率加权调整基线差异,随机效应Meta分析计算总体效应。
  • 共纳入2571例患者,其中1254例在主治医师第一周入ICU,1317例在第二周入ICU。
  • A站点和B站点的医院死亡率分别为25.8%和24.2%,中位ICU住院时长分别为4天和2天,中位机械通气时长分别为3天和3天。
  • 2周与1周最大连续性相比,调整后死亡率OR 1.01(95%CI 0.96-1.06),ICU住院时长-0.25天(95%CI -0.82至+0.32天),均无差异。
  • 机械通气患者中,2周与1周最大连续性相比,调整后死亡率OR 1.00(95%CI 0.87-1.16),ICU住院时长+0.06天(95%CI -0.78至+0.91天),机械通气时长+0.37天(95%CI -0.46至+1.21天),均无差异。
  • 探索性结局包括影像学、超声心动图和会诊医嘱。

证据类型、等级与局限

  • 证据类型:回顾性队列研究(目标试验模拟)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在两所内科ICU中,主治医师最大连续性2周与1周相比,临床结局无差异。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To compare outcomes for 2 weeks vs. 1 week of maximal patient-intensivist continuity in the ICU.

DESIGN: Retrospective cohort study.

SETTING: Two U.S. urban, teaching, medical ICUs where intensivists were scheduled for 2-week service blocks: site A was in the Midwest and site B was in the Northeast.

PATIENTS: Patients 18 years old or older admitted to a study ICU between March 1, 2017, and February 28, 2020.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: We applied target trial emulation to compare admission during an intensivist's first week (as a proxy for 2 wk of maximal continuity) vs. admission during their second week (as a proxy for 1 wk of maximal continuity). Outcomes included hospital mortality, ICU length of stay, and, for mechanically ventilated patients, duration of ventilation. Exploratory outcomes included imaging, echocardiogram, and consultation orders. We used inverse probability weighting to adjust for baseline differences and random-effects meta-analysis to calculate overall effect estimates. Among 2571 patients, 1254 were admitted during an intensivist's first week and 1317 were admitted during a second week. At sites A and B, hospital mortality rates were 25.8% and 24.2%, median ICU length of stay were 4 and 2 days, and median mechanical ventilation durations were 3 and 3 days, respectively. There were no differences in adjusted mortality (odds ratio [OR], 1.01 [95% CI, 0.96-1.06]) or ICU length of stay (-0.25 d [-0.82 d to +0.32 d]) for 2 weeks vs. 1 week of maximal continuity. Among mechanically ventilated patients, there were no differences in adjusted mortality (OR, 1.00 [0.87-1.16]), ICU length of stay (+0.06 d [-0.78 d to +0.91 d]), or duration of mechanical ventilation (+0.37 d [-0.46 d to +1.21 d]) for 2 weeks vs. 1 week of maximal continuity.

CONCLUSIONS: Two weeks of maximal patient-intensivist continuity was not associated with differences in clinical outcomes compared with 1 week in two medical ICUs.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Admon AJ, Cohen-Mekelburg S, Opatrny M, et al. Two Weeks Versus One Week of Maximal Patient-Intensivist Continuity for Adult Medical Intensive Care Patients: A Two-Center Target Trial Emulation. Crit Care Med. 2024. PMID: 38713002. doi:10.1097/CCM.0000000000006322

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。